INMED PHARMACEUTICAL

IN
Delayed Quote. Delayed  - 10/23 03:55:30 pm
4.42CAD -1.34%
Prev.4.4800
Open4.4600
High4.5000
Low4.3500
Volume2 638
Latest news
09/25
09/24
09/24
09/23
Chart INMED PHARMACEUTICALS INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance4,937,557,05
Spread/Res.-10%-41%-37%
Spread/Supp.2,8%2,8%2,8%
Support4,304,304,30
Financials
Sales 2021 - - -
Net income 2021 -15,3 M -11,6 M -11,6 M
Net Debt 2021 - - -
P/E ratio 2021 -2,23x
Yield 2021 -
Capitalization 23,1 M 17,6 M 17,5 M
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 11
Free-Float 98,8%
Company
InMed Pharmaceuticals Inc. is a pre-clinical-stage biopharmaceutical company. The Company specializes in the research and development of cannabinoid-based therapies combined with drug delivery systems. The Company operates through the segment of research and development of pharmaceutical cannabis...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2020-11-03 Earnings Release

Income Statement Evolution
Consensus
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 14,85 CAD
Last Close Price 4,42 CAD
Spread / Highest target 236%
Spread / Average Target 236%
Spread / Lowest Target 236%